Other names
Types
Causes
Common symptoms
Non-pharmacological treatments (therapies & others)
Drug treatments
Dietary molecular supplements
Immunity-booster / regenerative / stem-cell” drugs
Surgeries
Preventions
When to see a doctor
What to eat and what to avoid
Frequently Asked Questions (FAQ)

Autoimmune Polyendocrinopathy Candidiasis-Ectodermal Dystrophy (APECED) is a rare disease that starts in childhood. It happens when a gene called AIRE does not work properly. AIRE’s normal job is to “teach” the immune system, inside the thymus, to ignore the body’s own tissues. When AIRE fails, the immune system can attack many organs (autoimmunity). The most common problems are a long-lasting yeast infection of the skin, mouth, and nails (chronic mucocutaneous candidiasis), low blood calcium from hypoparathyroidism, and primary adrenal insufficiency (Addison’s disease). Many people also have skin, dental, liver, stomach, and reproductive gland problems. APS-1 is usually inherited in an autosomal recessive way (two faulty AIRE copies), though milder “non-classic” disease from certain dominant AIRE variants also exists. RUPress+3NCBI+3PMC+3

APS-1 (also called APECED) is a rare, inherited immune system disease that usually starts in childhood. It most often includes a “classic triad”: chronic mucocutaneous candidiasis (recurrent yeast infections of the mouth/skin), hypoparathyroidism (low parathyroid hormone causing low calcium), and primary adrenal insufficiency/Addison’s disease (the adrenal glands cannot make enough cortisol ± aldosterone). People may also develop other autoimmune problems (like hepatitis, intestinal problems, dental enamel defects, alopecia, keratitis, and asplenia). Diagnosis is clinical plus genetic testing for AIRE gene variants. Treatment focuses on replacing missing hormones, preventing adrenal crisis, and controlling candidiasis and other autoimmune issues. NCBI+2Orpha.net+2

Other names

APECED (Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy)
Autoimmune polyglandular syndrome type 1 (APS-1)
Polyglandular autoimmune syndrome type 1 (PGA-I)
These terms describe the same condition caused by AIRE gene defects. Immune Deficiency Foundation+1

Types

Classic APS-1 (autosomal recessive AIRE deficiency). Childhood onset. “Triad” of chronic mucocutaneous candidiasis, hypoparathyroidism, and primary adrenal insufficiency; many have ectodermal changes (dental enamel defects, nail changes). NCBI+1
Non-classic / dominant AIRE disease. Some people with a single (heterozygous) dominant-negative AIRE variant develop a later-onset, milder, or different set of autoimmune features; CMC may be absent. These cases broaden the spectrum beyond pure recessive disease. RUPress+2JCI+2
Phenotype-focused subsets (used in practice).
- CMC-predominant early childhood form. Recurrent oral/skin Candida infections often appear first. Frontiers
- Endocrine-predominant form. Hypoparathyroidism and/or Addison disease lead the picture. NCBI
- Cytokine-autoantibody–predominant form. High-titer autoantibodies to type I interferons (and to IL-17/IL-22) are characteristic and now used diagnostically. PLOS+1

Causes

Truth in a nutshell: the root cause is pathogenic variants in the AIRE gene. The rest of this list shows the detailed mechanisms and modifiers that explain how a single gene defect produces many problems and why people look different from each other.

Biallelic AIRE loss-of-function (autosomal recessive). The defining cause of classic APS-1; hundreds of variants reported. ScienceDirect+1
Failure of central T-cell tolerance in the thymus. Without working AIRE, tissue-restricted antigens are not displayed; self-reactive T cells escape. PMC
Defective medullary thymic epithelial cells (mTECs). AIRE orchestrates gene expression in mTECs; its loss alters antigen display and thymic architecture. PMC
High-affinity autoreactive T cells in the periphery. These cells survive selection and can attack organs. PMC
Autoantibodies to type I interferons (IFN-α/ω). Highly specific for APS-1 and contribute to infection susceptibility and immune dysregulation. PLOS
Autoantibodies to IL-17/IL-22 pathways. These impair mucosal antifungal immunity and help explain chronic Candida infections. Frontiers
Dominant-negative AIRE variants. Certain heterozygous mutations can poison the AIRE complex, causing non-classic APS-1. RUPress+1
Founder mutations in specific populations. High local frequencies lead to clusters (e.g., Finnish, Sardinian, Iranian Jewish cohorts). Oxford Academic
Modifier genes and HLA background. Genetic background can shape which organs are targeted and when. PMC
Environmental triggers (infections). Infections may unmask or amplify organ autoimmunity in genetically primed individuals. PMC
Epithelial/ectodermal vulnerability. Ectodermal structures (nails, enamel) are often involved; exact pathways relate to immune-epithelial interactions. NCBI
Mucosal immune defects. Th17 axis disruption weakens antifungal defense at skin and mucosa. Frontiers
Breakdown of B-cell tolerance. Autoreactive B cells produce diverse organ-specific autoantibodies (e.g., anti-21-hydroxylase, anti-parietal cell). NCBI
Immune endocrine crosstalk. Hormone-secreting cells are frequent immune targets (parathyroid, adrenal, gonads). NCBI
Age-dependent penetrance. Different components appear at different ages (CMC often first; endocrinopathies later). Oxford Academic
Sex-related influences. Some autoimmune components show female predominance (e.g., ovarian failure). NCBI
Chronic inflammation and tissue damage cycles. Ongoing autoreactivity sustains organ injury over time. PMC
Diagnostic delay. Missed early signs allow disease to evolve unchecked; this “cause” of severity is clinical, not genetic. Nature
Nutritional sequelae of endocrine failure. Hypoparathyroidism and adrenal insufficiency alter calcium and electrolyte balance, worsening symptoms. NCBI
Autoimmune liver and gut involvement. Secondary organ autoimmunity (autoimmune hepatitis, pernicious anemia) broadens disease impact. NCBI

Common symptoms

Chronic mouth/skin/nail Candida infections. Recurrent thrush, angular cheilitis, onychomycosis; due to impaired IL-17/IL-22 pathways. Frontiers
Tingling, cramps, or spasms from low calcium. Hypoparathyroidism lowers calcium; people may have muscle twitching or seizures. NCBI
Fatigue, weight loss, low blood pressure. Signs of Addison’s disease; may have darkening of skin and salt craving. NCBI
Skin changes. Vitiligo, alopecia, nail dystrophy, dry skin are frequent ectodermal features. PMC
Dental enamel defects. Thin or pitted enamel and early caries in childhood. NCBI
Eye irritation or dryness. Keratoconjunctivitis can cause red, painful, or gritty eyes. NCBI
Stomach problems. Nausea, anemia, or B12 deficiency from autoimmune gastritis/pernicious anemia. NCBI
Liver issues. Elevated liver enzymes or autoimmune hepatitis causing fatigue and jaundice in some. NCBI
Early ovarian failure. Irregular periods, infertility, or menopausal symptoms in young women. NCBI
Testicular dysfunction (less common). Low testosterone symptoms in males. NCBI
Thyroid disease. Some develop hypothyroidism with weight gain, cold intolerance, and tiredness. NCBI
Type 1 diabetes (in a minority). Thirst, frequent urination, and weight loss can occur. NCBI
Asplenia/splenomegaly or recurrent infections. Immune dysregulation raises infection risks. NCBI
Joint and muscle pains. Non-specific autoimmune inflammation may cause aches. PMC
Psychological stress and quality-of-life impact. Chronic symptoms, hospital visits, and dietary restrictions affect daily life. Nature

Diagnostic tests

A) Physical examination

General inspection for the “triad.” Look for oral thrush, dental enamel defects, skin/nail changes, and signs of adrenal insufficiency (weight loss, dark skin). This bedside check often raises the first suspicion. NCBI+1
Blood pressure and posture test (orthostatics). Low resting blood pressure and dizziness on standing point toward Addison’s disease. NCBI
Skin, hair, and nail exam. Vitiligo, alopecia, nail dystrophy, and candidal rashes are common and support the diagnosis. PMC
Oral exam. Persistent thrush on the tongue and mucosa, angular fissures, and enamel defects suggest CMC plus ectodermal involvement. Frontiers+1
Chvostek/Trousseau signs. Simple bedside tests to detect low calcium from hypoparathyroidism (facial twitch or carpal spasm). NCBI

B) “Manual” office tests

Bedside glucose check. Screens for diabetes in symptomatic patients (polyuria, polydipsia). NCBI
KOH prep or fungal microscopy from lesions. Quick confirmation of Candida in oral or skin lesions. Frontiers
Schirmer test for dry eyes. Measures tear production when ocular symptoms exist. NCBI
Neuromuscular irritability testing. Eliciting tetany with a sphygmomanometer (Trousseau) is a simple, office-based clue to hypocalcemia. NCBI
Orthostatic heart-rate/pressure log. Simple serial readings can track adrenal insufficiency severity. NCBI

C) Laboratory and pathology tests

Serum calcium, phosphate, magnesium, and intact PTH. Low calcium with inappropriately low PTH confirms hypoparathyroidism. NCBI
Morning cortisol and ACTH; ACTH stimulation test. Low cortisol with high ACTH (or suboptimal cortisol rise) indicates primary adrenal failure. NCBI
Thyroid panel (TSH, free T4). Screens for autoimmune hypothyroidism common in APS-1. NCBI
B12, CBC (MCV), and intrinsic factor/parietal cell antibodies. Detect and explain pernicious anemia. NCBI
Liver enzymes and autoimmune hepatitis markers (ANA, SMA, LKM). Identify autoimmune liver disease associated with APS-1. NCBI
Islet autoantibodies (GAD65, IA-2, ZnT8) and A1c. Evaluate for type 1 diabetes when symptoms or glucose abnormalities are present. NCBI
Anti-21-hydroxylase and anti-parathyroid antibodies. Organ-specific autoantibodies support autoimmune Addison’s and hypoPT. NCBI
Type I interferon autoantibodies (IFN-α/ω). Highly characteristic; now considered a helpful diagnostic “marker” even early on. PLOS+1
IL-17/IL-22 pathway autoantibodies. Explain CMC susceptibility; available in some centers. Frontiers
AIRE genetic testing (sequencing + deletion/duplication). Confirms the diagnosis; detects biallelic variants in classic APS-1 and dominant variants in non-classic disease. Family testing enables counseling. Oxford Academic+1

D) Electrodiagnostic tests

ECG. Hypocalcemia can prolong the QT interval and predispose to arrhythmias; ECG helps assess risk. NCBI
EEG (when seizures or paresthesias are concerning). Severe hypocalcemia may provoke seizures; EEG can assist evaluation. NCBI
Nerve conduction studies (select cases). Consider if chronic hypocalcemia or autoimmune neuropathy is suspected. NCBI

E) Imaging tests

Dental panoramic X-ray. Documents enamel hypoplasia, ectodermal findings, and dental complications. NCBI
Bone density scan (DXA). Long-standing hypocalcemia and steroid replacement may reduce bone density. NCBI
Adrenal imaging (only if atypical features). Used when the clinical/lab picture is unclear; not routinely needed for autoimmune Addison’s. NCBI
Liver ultrasound or elastography. Non-invasive evaluation when liver tests are abnormal. NCBI
Thyroid ultrasound. Helpful if nodules or unclear thyroid disease coexist. NCBI

Non-pharmacological treatments (therapies & others)

Adrenal crisis education & sick-day rules — Learn signs (severe weakness, vomiting, low BP) and how to double or triple hydrocortisone during fever/infection; carry an emergency steroid injection card/kit. Purpose: prevent life-threatening crisis. Mechanism: timely cortisol replacement covers stress needs. National Adrenal Diseases Foundation
Medical alert identification — Wear a bracelet/phone lock screen note saying “Primary Adrenal Insufficiency + Hypoparathyroidism.” Purpose: speed correct ER care. Mechanism: prompts immediate IV hydrocortisone and calcium if needed. National Adrenal Diseases Foundation
Regular endocrinology follow-up — Routine reviews of symptoms, blood pressure, electrolytes, calcium, vitamin D, and medication doses. Purpose: keep levels stable and adjust therapy early. Mechanism: surveillance prevents crises and complications. NCBI
Infection prevention for candidiasis — Good oral hygiene, rinse after inhaled steroids, keep skin folds dry, treat triggers. Purpose: reduce yeast overgrowth. Mechanism: lowers moisture/bioburden so antifungals work better. NCBI
Calcium & vitamin D lifestyle — Spread calcium intake through the day, maintain sunlight exposure (as safe), and time supplements away from thyroid pills/iron. Purpose: steady calcium control in hypoparathyroidism. Mechanism: improves absorption, reduces swings. NCBI
Fluids/salt balance — With adrenal insufficiency, maintain adequate fluids and, if on fludrocortisone, moderate salt per clinician advice. Purpose: stable blood pressure and potassium. Mechanism: supports mineralocorticoid replacement. Oxford Academic
Eye surface protection — Lubricating drops, UV protection, and prompt care for pain/redness to prevent scarring in autoimmune keratitis. Purpose: preserve vision. Mechanism: protects cornea and reduces inflammation triggers. PMC
Dental enamel care — Early pediatric dental care, fluoride, sealants, and repair of enamel hypoplasia; manage dry mouth. Purpose: prevent cavities and tooth loss. Mechanism: strengthens enamel and reduces acid damage. Pathology Labs
Skin & nail care — Emollients, gentle cleansers, protect nails/skin from trauma; treat alopecia/dermatitis supportively. Purpose: comfort and barrier protection. Mechanism: reduces microtrauma and secondary infection. PMC
Hepatic health habits — Avoid alcohol excess and hepatotoxic supplements; get hepatitis vaccines when appropriate. Purpose: protect against autoimmune hepatitis complications. Mechanism: reduces liver injury burden. PMC
GI support & nutrition — Manage diarrhea/malabsorption with dietitian help; lactose-free trials or low-oxalate diet if advised; correct fat-soluble vitamin deficits. Purpose: maintain weight and micronutrients. Mechanism: reduces irritants; optimizes absorption. New England Journal of Medicine
Bone health program — Weight-bearing exercise, adequate calcium/vitamin D; consider DEXA monitoring if long-term glucocorticoids. Purpose: prevent osteoporosis. Mechanism: supports bone remodeling and mineralization. Oxford Academic
Stress-dose plan for procedures — Pre-op steroid plan; ensure IV calcium availability if hypocalcemic risk. Purpose: avoid peri-operative crises. Mechanism: anticipates increased hormone needs. Immune Deficiency Foundation
Vaccinations & asplenia precautions — If functionally asplenic, get pneumococcal, meningococcal, Hib vaccines and urgent fever evaluation. Purpose: prevent severe sepsis. Mechanism: primes immunity against encapsulated bacteria. PMC
Sun/skin yeast management — Light, breathable clothing; prompt treatment of intertrigo. Purpose: reduce candida flares. Mechanism: lowers skin humidity and friction. NCBI
Psychosocial support — Counseling and patient groups for coping with chronic, multi-system disease. Purpose: reduce anxiety/depression, improve adherence. Mechanism: social support improves self-management. National Organization for Rare Disorders
Emergency home kit — Pre-filled hydrocortisone for injection, oral rehydration, glucose, thermometer, instruction card. Purpose: bridge to care during illness. Mechanism: rapid hormonal/volume support. National Adrenal Diseases Foundation
Medication timing routines — Fixed timing for hydrocortisone, fludrocortisone, calcitriol, calcium; separate from levothyroxine/iron. Purpose: stable levels and fewer interactions. Mechanism: consistent pharmacokinetics. Oxford Academic
Regular renal monitoring — Periodic urinalysis/kidney function, especially with APS-1-related tubulointerstitial nephritis risk. Purpose: detect early kidney issues. Mechanism: surveillance preserves function. BioMed Central
Ophthalmology safety plan — Early treatment of photophobia/pain; consider scleral lenses for severe dryness. Purpose: protect cornea. Mechanism: mechanical barrier and lubrication. PMC

Drug treatments

Hydrocortisone (oral) — Adrenal insufficiency. Class: glucocorticoid. Typical total daily dose split 2–3 times (e.g., 10 mg AM, 5 mg midday, 5 mg afternoon). Purpose: replace cortisol. Mechanism: restores glucocorticoid effects for energy, BP, stress. Side effects: weight gain, mood change, glucose elevation, bone loss (at higher doses). Sick-day: increase dose during fever/vomiting; emergency IM if unable to take orally. Oxford Academic
Fludrocortisone — If aldosterone deficiency. Class: mineralocorticoid. Typical 0.05–0.2 mg daily, titrated to BP, electrolytes, renin. Purpose: maintain salt/water balance. Mechanism: renal sodium retention. Side effects: edema, hypertension, low potassium. Oxford Academic
Calcitriol (active vitamin D) — Hypoparathyroidism. Class: vitamin D analog. Typical 0.25–2 µg/day in divided doses. Purpose: raise calcium. Mechanism: boosts gut calcium absorption without PTH. Side effects: hypercalcemia, hypercalciuria, kidney stones—monitor. NCBI
Elemental Calcium (oral) — Often 1–2 g/day in divided doses; type (carbonate vs citrate) per tolerance. Purpose: support serum calcium with calcitriol. Side effects: constipation, stones if excessive; separate from thyroid/iron. NCBI
Magnesium supplements — Correct low magnesium that worsens hypocalcemia. Mechanism: supports PTH release/action. Side effects: diarrhea (oral forms). NCBI
Fluconazole — Chronic mucocutaneous candidiasis. Class: azole antifungal. Typical 100–200 mg/day or pulse regimens; duration individualized. Mechanism: inhibits fungal ergosterol. Side effects: liver enzyme elevation, drug interactions. Use lowest effective dose and antifungal stewardship. NCBI
Topical antifungals (clotrimazole/nystatin) — Local therapy for oral/vulvovaginal/skin candidiasis. Low systemic risk; use after meals/bedtime as directed. NCBI
Levothyroxine — For autoimmune hypothyroidism if present. Take on empty stomach, same time daily; adjust by TSH/FT4. Side effects if over-treated: palpitations, bone loss. NCBI
Azathioprine — For autoimmune hepatitis or severe organ autoimmunity per specialist. Class: antimetabolite. Mechanism: lowers lymphocyte proliferation. Monitor CBC/LFTs; risks include infection, cytopenias. PMC
Budesonide/Prednisone (hepatic) — For autoimmune hepatitis induction in selected cases; dose tapered by response. Risks: glucose elevation, osteoporosis; protect bone. PMC
Topical ocular cyclosporine / corticosteroids — For autoimmune keratitis under ophthalmology. Mechanism: reduce corneal inflammation; careful monitoring to avoid infection/pressure rise. PMC
Prophylactic antibiotics (asplenia) — In some with functional asplenia, daily penicillin (per local policy) and urgent evaluation for fevers. Mechanism: reduce severe bacterial sepsis risk. PMC
Antidiarrheals / pancreatic enzymes (if malabsorption) — Symptom control and nutrient absorption support in GI involvement; dosing individualized. New England Journal of Medicine
Bile acid binders or fat-soluble vitamin repletion — If steatorrhea; replace vitamins A, D, E, K as measured. Monitor levels. New England Journal of Medicine
Levothyroxine timing caution — Separate from calcium/iron 4 hours to avoid poor absorption; this is a critical “drug–drug timing” rule. NCBI
Stress-dose Hydrocortisone (IM/IV) — 50–100 mg IM/IV in crisis or major surgery, then taper as able; hospital protocol driven. Life-saving. National Adrenal Diseases Foundation
Antifungal rotation strategy — For recurrent candidiasis with resistance/intolerance, specialist may rotate azoles or use echinocandins short-term. Monitor liver and interactions. NCBI
Proton-pump inhibitor caution — If needed for reflux, use the lowest effective dose; PPIs can affect magnesium/calcium and candidiasis risk; reassess regularly. NCBI
JAK-inhibitor (e.g., baricitinib) in select cases — Specialist-led, off-label in APS-1 research settings for interferon-driven inflammation. Monitor infection, cytopenias, lipids. Not routine first-line. New England Journal of Medicine
Vaccines — Not a “drug treatment” but critical preventative medicine, especially if asplenic; schedule per guidelines. Monitor for autoimmune flares with your team. PMC

Dietary molecular supplements

Discuss with your clinician before starting supplements; aim to correct deficiencies and avoid interactions.

Vitamin D (cholecalciferol or calcitriol as prescribed) — Central to calcium balance in hypoparathyroidism; dosing individualized to maintain calcium and avoid kidney stones. Mechanism: increases gut calcium absorption. NCBI
Calcium (elemental) — Divided doses with meals; do not take near thyroid meds/iron. Mechanism: provides substrate to raise serum calcium with calcitriol. NCBI
Magnesium — Corrects deficiency that worsens hypocalcemia and cramps; choose tolerated forms. NCBI
Vitamin A/E/K (if fat malabsorption) — Replace measured deficits to protect vision, nerves, and coagulation. Monitor levels to avoid toxicity. New England Journal of Medicine
Probiotics (adjunctive) — May help reduce antibiotic-associated diarrhea; evidence for candidiasis prevention is mixed; use cautiously in immunosuppression. PMC
Omega-3 fatty acids — Heart and anti-inflammatory support; modest effect size; avoid if bleeding risk. PMC
Folate/B12 — Replace documented deficiencies (due to malabsorption or dietary limits); supports hematologic and neurologic health. New England Journal of Medicine
Iron — Only if iron-deficient; separate from levothyroxine/calcium to avoid absorption issues. NCBI
Zinc — If low or with recurrent infections/poor wound healing; excessive doses can lower copper—monitor. PMC
Electrolyte solutions during illness — Oral rehydration helps prevent adrenal crisis dehydration; pair with stress-dose steroids per plan. National Adrenal Diseases Foundation

Immunity-booster / regenerative / stem-cell” drugs

There are no proven stem-cell or “regenerative” cures for APS-1 at this time. Care is mainly hormone replacement and targeted immunomodulation. Experimental JAK-inhibition is being studied for interferon-driven inflammation. The following entries explain the landscape so you can discuss options safely with your specialist. New England Journal of Medicine

JAK inhibitors (e.g., baricitinib) — Mechanism: block JAK-STAT signaling downstream of interferons to reduce tissue inflammation. Dosing is specialist-led; monitor CBC, LFTs, lipids, and infection risk. Not standard of care; reserved for select, refractory cases in centers with expertise. New England Journal of Medicine
Targeted biologics for organ autoimmunity (case-by-case) — Agents like rituximab (B-cell depletion) or anti-TNF may be used for specific organ disease under subspecialist guidance when conventional therapy fails. Risks: serious infection, infusion reactions; benefits limited to select scenarios. Evidence in APS-1 is limited. PMC
Hematopoietic stem-cell transplantation (HSCT) — Not routine for APS-1 because risks are high and benefit uncertain; may be discussed only in exceptional research contexts. Mechanism: replaces immune system; risks: GVHD, infection. PMC
Interferon-pathway modulation under trials — Research focuses on reducing excessive interferon signaling seen in APS-1. Patients should enroll in trials if eligible. PMC
Low-dose naltrexone (LDN) — Sometimes proposed for autoimmune symptoms; robust evidence in APS-1 is lacking; discuss risks/benefits. PMC
Thymic/central tolerance restoration concepts — Future therapies may aim to restore AIRE-like tolerance, but this remains experimental science today. New England Journal of Medicine

Surgeries

Dental restorative procedures — Fillings/veneers/crowns for enamel hypoplasia to prevent decay and pain. Why: improves chewing, nutrition, and quality of life. Pathology Labs
Ocular surface procedures — Amniotic membrane grafts or keratoplasty in severe keratitis/scarring. Why: protect/restore vision after medical options. PMC
Esophageal dilation — In strictures from chronic esophageal candidiasis, specialists may dilate to relieve dysphagia, alongside antifungals. NCBI
Cholecystectomy/other GI surgery — Rare, only for specific complications (e.g., gallstones, severe malabsorption complications) after full medical management. New England Journal of Medicine
Parathyroid-related procedures — Surgery is uncommon in APS-1 hypoparathyroidism because glands are autoimmune-damaged; management is medical. Considered only for distinct surgical problems. NCBI

Preventions

Keep an adrenal emergency plan and kit at home/work/school. National Adrenal Diseases Foundation
Do not skip hormone replacements; use phone reminders. Oxford Academic
Promptly treat fevers/vomiting with stress-dose steroids and hydration; seek urgent care if worsening. National Adrenal Diseases Foundation
Oral/skin hygiene to reduce candidiasis (brush/floss; dry skin folds). NCBI
Vaccinations kept up-to-date; extra attention if asplenia. PMC
Routine labs (electrolytes, calcium, kidney function, liver tests) and dose checks. NCBI
Eye and dental check-ups twice yearly (or as advised). Pathology Labs
Medication timing to avoid interactions (levothyroxine away from calcium/iron). NCBI
Avoid hepatotoxic substances; cautious use of alcohol/OTC supplements. PMC
Carry medical ID at all times. National Adrenal Diseases Foundation

When to see a doctor

Immediately (ER): severe vomiting/diarrhea with inability to keep pills down; fainting/very low blood pressure; severe weakness/confusion; fever with shaking chills (especially if asplenic); severe eye pain/redness or sudden vision changes. National Adrenal Diseases Foundation+1
Urgent clinic visit: new mouth/skin yeast plaques not improving; muscle cramps/tingling (possible low calcium); darkening skin, salt craving, dizziness; yellow eyes or dark urine (possible liver issue); persistent diarrhea/weight loss. NCBI+1
Routine: medication refills/monitoring, vaccination review, dental/eye checks, dietitian support. NCBI

What to eat and what to avoid

Eat: balanced meals with adequate calcium (dairy or fortified alternatives, leafy greens), magnesium (nuts, legumes), and protein; plenty of fluids; small frequent meals if nausea. These help maintain calcium and energy levels. NCBI
If advised by your team, limit: oxalate-heavy foods (spinach, beets, nuts) if you have high urine calcium/stone risk; high-sugar foods that worsen oral yeast; alcohol due to liver risk. Separate levothyroxine from calcium/iron by 4 hours. New England Journal of Medicine+2NCBI+2

Frequently Asked Questions (FAQ)

Is APS-1 the same as APS-2?
No. APS-1 is a monogenic (AIRE) childhood-onset syndrome with candidiasis and hypoparathyroidism; APS-2 is polygenic, adult-onset (Addison + thyroid/diabetes). PMC
How is APS-1 diagnosed?
Clinical triad features, AIRE genetic testing, and characteristic type-I interferon autoantibodies support the diagnosis. NCBI
Is APS-1 curable?
There is no cure today. Treatment replaces missing hormones, controls infections/autoimmunity, and prevents crises. Research on interferon-pathway drugs is ongoing. New England Journal of Medicine
Can children live normal lives?
With careful monitoring, emergency plans, and replacement therapy, many can attend school and participate fully. Early recognition prevents complications. National Organization for Rare Disorders
Will I always need steroids?
If you have primary adrenal insufficiency, yes, lifelong glucocorticoid ± mineralocorticoid replacement is standard. Oxford Academic
Are antifungals lifelong?
Some need intermittent or chronic suppressive therapy; aim for the lowest effective dose to reduce resistance and liver side effects. NCBI
What about pregnancy?
Most meds can be managed safely with specialist care; adrenal and calcium levels require close adjustment; deliver with an emergency plan. Oxford Academic
Do vaccines cause flares?
Vaccines are important, especially with asplenia. Decisions are personalized; discuss timing with your team. PMC
Can I exercise?
Yes—within your energy limits. Hydrate, carry snacks, and follow stress-dose advice during illness or strenuous events. National Adrenal Diseases Foundation
Are “immune boosters” safe?
Be cautious. Many supplements lack evidence and some stress the liver or interact with meds. Ask your clinician first. PMC
Could kidneys be affected?
Yes—APS-1 can include autoimmune kidney problems; periodic screening helps catch issues early. BioMed Central
What eye problems occur?
Autoimmune keratitis and dry eye can occur; early treatment prevents scarring and vision loss. PMC
Why are my teeth affected?
Enamel hypoplasia can be part of APS-1; proactive dental care protects teeth. Pathology Labs
Is HSCT a cure?
No routine role; risks are high and benefits uncertain—consider only in research/exceptional cases. PMC
What promising research exists?
Targeting interferon signaling (e.g., JAK-inhibition) is under study; ask about clinical trials at expert centers. New England Journal of Medicine

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.